Thermo Fisher Scientific Organic revenue (change on a year)
Organic revenue (change on a year) at Thermo Fisher Scientific came to 6% for the quarter to 26 Sep 2026, up 3.0 points from a year earlier.
As Thermo Fisher Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 21 Oct 2026.
By quarter
| Period ending | Organic revenue (change on a year) | Change on a year | Filed |
|---|---|---|---|
| 26 Sep 2026 | 6% | up 3.0 points | 21 Oct 2026 |
| 27 Jun 2026 | 5% | up 3.0 points | 23 Jul 2026 |
| 28 Mar 2026 | 1% | unchanged | 23 Apr 2026 |
| 27 Sep 2025 | 3% | up 3.0 points | 22 Oct 2025 |
| 28 Jun 2025 | 2% | up 3.0 points | 23 Jul 2025 |
| 29 Mar 2025 | 1% | up 5.0 points | 23 Apr 2025 |
| 28 Sep 2024 | 0% | up 3.0 points | 1 Nov 2024 |
| 29 Jun 2024 | −1% | up 2.0 points | 2 Aug 2024 |
| 30 Mar 2024 | −4% | up 4.0 points | 3 May 2024 |
| 30 Sep 2023 | −3% | down 2.0 points | 3 Nov 2023 |
| 1 Jul 2023 | −3% | down 6.0 points | 4 Aug 2023 |
| 1 Apr 2023 | −8% | down 11.0 points | 5 May 2023 |
| 1 Oct 2022 | −1% | — | 4 Nov 2022 |
| 2 Jul 2022 | 3% | — | 5 Aug 2022 |
| 2 Apr 2022 | 3% | — | 6 May 2022 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Shown as the change on the same period a year earlier, as the company prints it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Thermo Fisher Scientific: Remaining performance obligations · Product revenues · Service revenues · Consumables revenue · Instruments revenue · Clinical research revenue · Research and safety market channel revenue · Pharma services revenue · Biosciences revenue · BioProduction revenue · Chromatography and mass spectrometry revenue · Electron microscopy revenue · Genetic sciences revenue · Laboratory products revenue · Healthcare market channel revenue · Chemical analysis revenue · Clinical diagnostics revenue · ImmunoDiagnostics revenue · Transplant diagnostics revenue · Microbiology revenue · Laboratory Products and Biopharma Services revenue · Life Sciences Solutions revenue · Analytical Instruments revenue · Specialty Diagnostics revenue · financial statements
Every KPI and segment of TMO, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.